Ιωάννη Κρανιδιώτη 2

555 35, Πυλαία, Θεσσαλονίκη

+30 2310 475 662

Καθημερινές : 9:00 - 14:00

info@hcds.gr

https://hcds.gr/epikoinonia/

Heart Groups: Patients with COVID-19 Should Continue ACE Inhibitors & ARBs

Patients with novel coronavirus disease (COVID-19) who have underlying hypertension, heart failure, or ischemic heart disease should not stop taking their angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), according to a new statement from the American Heart Association, the American College of Cardiology, and the Heart Failure Society of America.

In a correspondence in the Lancet Respiratory Medicine, researchers proposed that ACE-inhibitors and ARBs could increase the risk for developing severe COVID-19. The coronavirus binds to target cells through ACE 2, the expression of which is increased when patients take these drugs.

Dr. Karol Watson, associate editor with NEJM Journal Watch Cardiology, comments: “Some have suggested that utilization of renin–angiotensin–aldosterone system blockers may increase the ability of the virus to enter lungs, although there is no clinical data to support that this is actually true. This current statement should give clinicians comfort to continue use of RAAS blockers during these strange and unsettling times.”


original article: jwatch

Σχολιάστε

Αυτός ο ιστότοπος χρησιμοποιεί το Akismet για να μειώσει τα ανεπιθύμητα σχόλια. Μάθετε πώς υφίστανται επεξεργασία τα δεδομένα των σχολίων σας.

στοιχεία σύνδεσης

Kατηγορίες

Recent Posts

Ιστορικό

κοινοποιήστε στο :

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on skype
Skype
Share on email
Email